| Titolo |
Pubblicato in |
Anno |
| Multi-readout thermoplasmonic biosensor for rapid detection of oligonucleotides |
VIEW |
2025 |
| A novel AML1-ETO/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabilizing IGFBP2 in t(8;21) acute myeloid leukemia |
EXPERIMENTAL HEMATOLOGY & ONCOLOGY |
2024 |
| Nuclear miR-223 affects chromatin organization and regulates Flotillin-1 gene expression in myeloid progenitors |
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES |
2024 |
| Nuclear miRNAs: Gene Regulation Activities |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2024 |
| Plasmonic biosensors for real-time monitoring of harmful pathogens and biomolecules |
2024 IEEE Research and Applications of Photonics in Defense Conference, RAPID 2024 |
2024 |
| MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients |
LEUKEMIA |
2023 |
| Editorial: Genetic/epigenetic mechanisms and related clinical strategy in leukemia |
FRONTIERS IN ONCOLOGY |
2023 |
| Biomarkers in acute myeloid leukemia: From state of the art in risk classification to future challenges of RNA editing as disease predictor and therapy target |
ASPECTS OF MOLECULAR MEDICINE |
2023 |
| The epigenetic/transcriptional activity of nuclear mir-223 regulates flotillin-1 expression and function in myeloid differentiation |
1st Epigenetics Society International Meeting “Epigenetics of Disease and Development” |
2023 |
| Ascorbate plus buformin in AML. A metabolic targeted treatment |
CANCERS |
2022 |
| A tribute to professor Sergio Adamo, full professor of histology and embryology at Sapienza university, Rome |
EUROPEAN JOURNAL OF TRANSLATIONAL MYOLOGY |
2022 |
| Serum albumin and nucleic acids biodistribution. From molecular aspects to biotechnological applications |
IUBMB LIFE |
2022 |
| The gene promoter binding activity of miR-223 induces flotillin-1 expression and function to regulate myeloid differentiation |
HAEMATOLOGICA |
2022 |
| Ascorbate plus buformin in AML: a metabolic targeted treatment |
CANCERS |
2022 |
| Thalassemias. From gene to therapy |
MOLECULAR ASPECTS OF MEDICINE |
2021 |
| Molecular imaging in immuno-oncology: current status and translational perspectives |
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS |
2020 |
| Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells |
CELLS |
2020 |
| Aptamer-based technology for radionuclide targeted imaging and therapy: a promising weapon against cancer |
EXPERT REVIEW OF MEDICAL DEVICES |
2020 |
| Genetic lesions disrupting calreticulin 3′-untranslated region in JAK2 mutation-negative polycythemia vera |
AMERICAN JOURNAL OF HEMATOLOGY |
2020 |
| Ruxolitinib binding to human serum albumin. Bioinformatics, biochemical and functional characterization in JAK2V617F+ cell models |
SCIENTIFIC REPORTS |
2019 |
